Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Convergence of nanotechnology and cancer prevention: are we there yet?

Cancer prevention research (Philadelphia, Pa.) - 1 Oct 2014

Menter David G, Patterson Sherri L, Logsdon Craig D, Kopetz Scott, Sood Anil K, Hawk Ernest T

Abstract excerpt

Nanotechnology is emerging as a promising modality for cancer treatment; however, in the realm of cancer prevention, its full utility has yet to be determined. Here, we discuss the potential of integrating nanotechnology in cancer prevention to augment early diagnosis, precision targeting, and controlled release of chemopreventive agents, reduced toxicity, risk/response assessment, and personalized point-of-care...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents
Share to Anticarcinogenic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biocompatible Materials

Share to Chemoprevention

Share to Drug Delivery Systems

Share to Immune System

Share to Liposomes

Share to Nanotechnology

Source

Open in PubMed Open full text

Identifiers

PMID: 25060262
DOI: 10.1158/1940-6207.CAPR-14-0079
PMCID: PMC4307396

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Convergence of nanotechnology and cancer prevention: are we there yet?PMID 25060262Read ↗

Cancer prevention: past challenges and future directionsSemantic proximity Read ↗

Precancer Atlas to Drive Precision Prevention Trials.Semantic proximity Read ↗

Development of cancer chemopreventive drugs based on mechanistic approaches.Semantic proximity Read ↗

Precision in Practice: Nanotechnology and Targeted Therapies for Personalized CareSemantic proximity Read ↗

From Phenomenon to Precision: Addressing Key Challenges in Harnessing Nanomaterial-Induced Biological Responses for Cancer TherapySemantic proximity Read ↗

CNTs as Excellent Adjuvants for Anticancer Therapeutic Strategies and Cancer Diagnosis: A Plethora of Laboratory Studies versus Few Clinical Trials and Still No Clinical ApplicationSemantic proximity Read ↗

The hallmarks of premalignant conditions: a molecular basis for cancer prevention.Semantic proximity Read ↗

Advances in Cancer Treatment through Nanotheranostics and Emerging TherapiesSemantic proximity Read ↗

Precautionary Principle: Cancer Prevention Efforts During Critical Periods of Growth and Development.Semantic proximity Read ↗

Chemopreventive and Anticancer Role of Resveratrol against non-melanoma skin cancer (NMSC): Focusing on cellular and molecular mechanisms and biochemistrySemantic proximity Read ↗

Carcinogenesis of head and neck cancer and the role of chemoprevention in its reversal.Semantic proximity Read ↗

Leading Neuroblastoma Cells To Die by Multiple Premeditated Attacks from a Multifunctionalized NanoconstructSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.